Skip to content
Trial Eligibility
Menu

Breast Cancer Clinical Trials near Aurora, CO

72 studies for Breast Cancer are recruiting at 225 sites within 50 miles of Aurora, Colorado, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Breast Cancer trials in the US or all trials near Aurora.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Breast Cancer studies enrolling near Aurora

Showing the 50 nearest of 72 studies.
  1. Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

    NCT05929768

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Rocky Mountain Cancer Centers-Aurora (Aurora, CO); AdventHealth Porter (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    33 sites within 50 mi
  2. S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

    NCT03723928

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Rocky Mountain Cancer Centers-Aurora (Aurora, CO); Colorado Blood Cancer Institute (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    26 sites within 50 mi
  3. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    NCT06418204

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Rocky Mountain Cancer Centers-Aurora (Aurora, CO); Colorado Blood Cancer Institute (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    15 sites within 50 mi
  4. Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

    NCT05812807

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UCHealth University of Colorado Hospital (Aurora, CO); AdventHealth Porter (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    11 sites within 50 mi
  5. De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

    NCT04852887

    • Phase 3
    • Ages 50 to 70 years
    • Sex: All

    Nearest sites: UCHealth University of Colorado Hospital (Aurora, CO); Rose Medical Center (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  6. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Rocky Mountain Regional VA Medical Center (Aurora, CO); UCHealth University of Colorado Hospital (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  7. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    NCT05879926

    • Phase 3
    • Ages 18 to 60 years
    • Sex: Female

    Nearest sites: UCHealth University of Colorado Hospital (Aurora, CO); Saint Joseph Hospital - Cancer Centers of Colorado (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  8. ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

    NCT06876714

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UCHealth University of Colorado Hospital (Aurora, CO); Kaiser Permanente-Franklin (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  9. Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

    NCT06058377

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UCHealth University of Colorado Hospital (Aurora, CO); UCHealth - Cherry Creek (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  10. Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

    NCT01185132

    • Phase 3
    • Ages 40 years and older
    • Sex: All

    Nearest sites: Rocky Mountain Cancer Centers - Aurora (Aurora, CO); Rocky Mountain Cancer Centers - Thornton (Thornton, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  11. The Immune System's Response to Young Women's Breast Cancer

    NCT01503190

    • Observational
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: University of Colorado Denver (Aurora, CO); Denver Health Hospital Authority (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  12. MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

    NCT03053193

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Rocky Mountain Cancer Centers (Aurora, CO); University of Colorado Cancer Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  13. Improving Care for Rural Patients With Solid Tumors

    NCT04916990

    • Interventional
    • Ages 18 to 99 years
    • Sex: All

    Nearest sites: University of Colorado Hospital (Aurora, CO); Highlands Ranch Hospital (Highlands Ranch, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  14. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest sites: Massive Bio SYNERGY-AI site (Aurora, CO); Massive Bio SYNERGY-AI site (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  15. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    NCT05564377

    • Phase 2
    • Ages Any age
    • Sex: All

    Nearest sites: UCHealth University of Colorado Hospital (Aurora, CO); Medical Center of the Rockies (Loveland, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  16. The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

    NCT06377852

    • Phase 3
    • Ages 60 years and older
    • Sex: All

    Nearest sites: University of Colorado Anschutz Medical Campus (Aurora, CO); UCHealth Cherry Creek Medical Center (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  17. A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

    NCT06312176

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Colorado Anschutz Medical Campus ( Site 0061) (Aurora, CO); UCHealth Cherry Creek Medical Center ( Site 0094) (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

    NCT06430541

    • Phase 1
    • Ages 21 years and older
    • Sex: Female

    Nearest sites: Outpatient CTRC (Aurora, CO); University of Colorado Cancer Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

    NCT06435429

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Colorado-Cancer Center-PPDS (Aurora, CO); Rocky Mountain Cancer Centers (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

    NCT07085767

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Clinical Trial Site (Aurora, CO); Clinical Trial Site (Denver, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

    NCT01042379

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado Cancer Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. The PREDICT Registry:

    NCT03448926

    • Observational
    • Ages 30 to 85 years
    • Sex: Female

    Nearest site: University of Colorado Anschutz Medical Campus (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

    NCT03606967

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCHealth University of Colorado Hospital (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

    NCT05059444

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study of NX-1607 in Adults With Advanced Malignancies

    NCT05107674

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado School of Medicine (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

    NCT05768139

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado Cancer Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

    NCT05902988

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado Cancer Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado Cancer Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

    NCT06103864

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. CtDNA Based MRD Testing for NAC Monitoring in TNBC

    NCT06230185

    • Observational
    • Ages 18 years and older
    • Sex: Female

    Nearest site: University of Colorado Cancer Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    NCT06253871

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado Cancer Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

    NCT06369285

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado School of Medicine (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

    NCT06380751

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

    NCT06401421

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

    NCT06686394

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado Anschutz Medical Campus ( Site 0057) (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. E-Mindfulness Approaches for Living After Breast Cancer

    NCT06748222

    • Phase 3
    • Ages 18 to 50 years
    • Sex: All

    Nearest site: UCHealth University of Colorado Hospital (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

    NCT06764940

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University Of Colorado Hospital - Anschutz Cancer Pavilion (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

    NCT06784193

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

    NCT06799065

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado Denver (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

    NCT06908928

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Anschutz Medical Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

    NCT07001241

    • Phase 2
    • Ages 18 to 89 years
    • Sex: All

    Nearest site: University of Colorado Anschutz Medical Campus (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

    NCT07100106

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Colorado Cancer Center (Aurora, CO)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. The Vanguard Study: Testing a New Way to Screen for Cancer

    NCT06995898

    • Interventional
    • Ages 45 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Kaiser Permanente-Franklin (Denver, CO); Kaiser Permanente-Lone Tree (Lone Tree, CO)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  44. A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

    NCT06492616

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: St. Joseph Hospital-Cancer Centers of Colorado (Denver, CO); Rocky Mountain Cancer Centers, LLP (Lone Tree, CO)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  45. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    NCT06966700

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Intermountain Health Cancer Center Saint Joseph ( Site 0062) (Denver, CO); Rocky Mountain Cancer Centers (RMCC) ( Site 8006) (Denver, CO)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  46. ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

    NCT07007559

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Saint Joseph Hospital - Cancer Centers of Colorado (Denver, CO); Lutheran Hospital - Cancer Centers of Colorado (Golden, CO)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  47. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: Rocky Mountain Cancer Center (Denver, CO)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

    NCT04787042

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute at HealthONE (Denver, CO)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

    NCT05216432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: HealthONE (Denver, CO)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

    NCT05232916

    • Phase 3
    • Ages 18 to 100 years
    • Sex: All

    Nearest site: Rocky Mountain Cancer Centers (Denver, CO)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Breast Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.